Patient investors who ride out the storm could be rewarded down the road.

The surgical robotics maker posts better-than-expected quarterly earnings as it begins rollout of cardiac procedures.

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for ...

Intuitive Machines stock is still a "Buy" amid a 72% gain and reaching out price target. Here's what investors need to know.

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Jan 22 (Reuters) - Intuitive Surgical on Thursday beat Wall Street estimates for fourth-quarter profit and revenue on growing ...

Intuitive Machines has agreed to acquire Lanteris Space Systems in a pending $800 million deal that would expand its role into vertically integrated space infrastructure. The company has also been ...

This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.